SYNOPSIS: A global data analytics company, via its US subsidiary, invested $3 million in Healtheon AI through SAFE notes, gaining exposure to healthcare AI, with potential conversion into equity upon future funding events.
During Thursday’s trading session, shares of an AI-driven analytics, data engineering, and consulting firm surged more than 9 percent on BSE after entering into an agreement to make a strategic investment, amounting to $3 million, in a US healthcare firm.
With a market cap of Rs. 5,884 crores, shares of Latent View Analytics Limited are currently trading in the green at Rs. 283.9 on BSE, up by 9 percent, as against its previous closing price of Rs. 260.65. The stock has delivered negative returns of around 24 percent in one year, and has fallen by over 13 percent in the last one month.
What’s the News:
According to the latest disclosures on the stock exchanges, LatentView Analytics Limited, through its material wholly owned subsidiary, LatentView Analytics Corporation (incorporated in New Jersey), has entered into a Simple Agreement for Future Equity (SAFE) to make a strategic investment in Healtheon AI Inc., a Delaware-based entity.
The investment, amounting to $3 million, is aimed at gaining exposure to Healtheon AI’s capabilities in developing agentic AI frameworks for Revenue Cycle Management (RCM) services tailored for healthcare providers in the United States.
The transaction is expected to be completed on or before 7th April 2026. Under the terms of the SAFE agreement, the investment may be converted into SAFE Preferred Stock upon the occurrence of specific trigger events, including future equity fundraising rounds by the target entity or other agreed conditions.
Financials & More:
Latent View Analytics Limited is an India-based Data Analytics Company, with a primary objective to enable clients to develop and deploy result-oriented analytics solutions that shall enable them to make smarter decisions using their data on an ongoing basis. These solutions enable clients to improve their marketing performance, efficiently trade off risks against the available opportunities, maximise customer value and increase employee effectiveness.
With 1,650+ employees, LatentView is a trusted partner to enterprises worldwide, including over 40 Fortune 500 companies in the technology, financial services, cpg, retail, and healthcare sectors, with clients across the United States, Chile, Mexico, Germany, UK, Netherlands, and Singapore,
The company reported a growth in revenue from operations, experiencing a year-on-year increase of around 22 percent, from Rs. 228 crores in Q3 FY25 to Rs. 278 crores in Q3 FY26. The growth was primarily led by the Financial Services and Technology practices, which grew by 20.6 percent and 6.2 percent, respectively.
Likewise, its net profit increased during the same period from Rs. 43 crores to Rs. 51 crores, representing a rise of about 19 percent YoY. Further, Latent View Analytics maintained an adjusted EBITDA margin at 23 percent, supported by operational discipline, despite the impact of one‑time costs of nearly Rs. 5 crores. Excluding these one‑time items, adjusted EBITDA margin for the quarter would have been 24.6 percent.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post IT stock jumps 9% after $3 Million AI deal with US healthcare firm appeared first on Trade Brains.